Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.jchf.2017.02.016

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients

..., Roadmap Study Investigators
2
JACC: Heart Failure13.00
Volume: 5, Issue: 7, Pages: 518 - 527
Published: Jul 1, 2017
Abstract
The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years. The ROADMAP trial was a prospective nonrandomized observational study of 200 patients (97 with a left ventricular assist device [LVAD], 103 on optimal medical management [OMM]) that showed that survival with...
Paper Fields
Paper Details
Title
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients
DOI
doi.org/10.1016/j.jchf.2017.02.016
Published Date
Jul 1, 2017
Journal
JACC: Heart Failure
Volume
5
Issue
7
Pages
518 - 527
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.